NCT00287417
Completed
Not Applicable
Nuchal Translucency Study - PAPP-A
University Hospital, Strasbourg, France7 sites in 1 country20,000 target enrollmentJuly 2003
ConditionsDown Syndrome
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Down Syndrome
- Sponsor
- University Hospital, Strasbourg, France
- Enrollment
- 20000
- Locations
- 7
- Status
- Completed
- Last Updated
- 14 years ago
Overview
Brief Summary
The aim of the study is to evaluate the risk of Down syndrome during the first trimester of the pregnancy. The risk assessment is evaluated using early ultrasound and maternal biochemical markers.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Female \> 18 years old
Exclusion Criteria
- •Maternal age \< 18 years old, twin pregnancy
Outcomes
Primary Outcomes
Not specified
Study Sites (7)
Loading locations...
Similar Trials
Completed
Not Applicable
Non Invasive Prenatal Testing of Down SyndromeDown SyndromeNCT02127515Assistance Publique - Hôpitaux de Paris2,111
Completed
Not Applicable
Follow up of Increased Nuchal Translucency :Study of 2010 to 2018 of Limoges HospitalUltrasound Fetal MedicineNCT04028453University Hospital, Limoges392
Unknown
Not Applicable
Non Invasive Prenatal Test of Rare Genetic Diseases: Application to Rare Intellectual DisabilitiesGenetic Disorders in PregnancyNCT03688594University Hospital, Strasbourg, France60
Completed
Not Applicable
Influence of Prenatal Counseling in Invasive TestingGenetic CounselingPrenatal DiagnosisNCT04119349Hospital Clinic of Barcelona75
Withdrawn
Not Applicable
Prenatal diagnosis of Down's Syndrome using isolation of foetal cells from cervical mucous and peripheral blood during first trimester of pregnancyPregnant womenReproductive Health and Childbirth - Other reproductive health and childbirth disordersHuman Genetics and Inherited Disorders - Down's syndromeACTRN12606000460505Genetic Technologies Ltd2,000